Cargando…
Augmented efficacy with the combination of blockade of the NOTCH-1 pathway, Bortezomib and Romidepsin in a murine MT-1 adult T cell leukemia model
Adult T-cell leukemia (ATL) is an aggressive malignancy caused by human T-cell lymphotropic virus I (HTLV-1). There is no accepted curative therapy for ATL. We have reported that certain ATL patients have increased Notch-1 signaling along with constitutive activation of the NF-κB pathway. Physical a...
Autores principales: | Yu, Ping, Petrus, Michael N., Ju, Wei, Zhang, Meili, Conlon, Kevin C., Nakagawa, Masao, Maeda, Michiyuki, Bamford, Richard N., Waldmann, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329116/ https://www.ncbi.nlm.nih.gov/pubmed/25118879 http://dx.doi.org/10.1038/leu.2014.241 |
Ejemplares similares
-
Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia
por: Ju, Wei, et al.
Publicado: (2014) -
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia
por: Zhang, Meili, et al.
Publicado: (2015) -
Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib
por: Hui, Kwai Fung, et al.
Publicado: (2015) -
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia
por: Daenthanasanmak, Anusara, et al.
Publicado: (2020) -
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
por: Søgaard, Ole S., et al.
Publicado: (2015)